| Long name | p53 Primary Polyclonal Antibody |
| Also known as | p53 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | p53 |
| Specificity | This is a highly specific antibody against p53 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Source | Synthetic peptide |
| Gene ID number | 7157 |
| Swiss Prot | P04637 |
| Tested Applications | WB |
| Recommended dilutions | 000), WB (1:2 |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, Implicated in Notch signaling cross-over, In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis, Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1, Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process, Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters, Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1, Isoform 7 inhibits isoform 1-mediated apoptosis, LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation, One of the activated genes is an inhibitor of cyclin-dependent kinases, Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492), induces growth arrest or apoptosis depending on the physiological circumstances and cell type, or by repression of Bcl-2 expression, the function is largely independent of transcription, thus stopping cell cycle progression, Acts as a tumor suppressor in many tumor types |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | Antigen NY-CO-13, BCC7, Cellular tumor antigen p53, LFS1, Phosphoprotein p53, TP53, TRP53, Tumor suppressor p53, P53 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | p53 |
| Short name | p53 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | p53 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 11998 |
| Gene | TP53 |
| Long gene name | tumor protein p53 |
| Synonyms | p53 LFS1 |
| Synonyms name | Li-Fraumeni syndrome |
| Locus | 17p13, 1 |
| Discovery year | 1986-01-01 |
| GenBank acession | AF307851 |
| Entrez gene record | 7157 |
| Pubmed identfication | 6396087 3456488 2047879 |
| RefSeq identity | NM_000546 |
| Havana BLAST/BLAT | OTTHUMG00000162125 |
| Locus Specific Databases | IARC TP53 Mutation Database p53 UMD TP53 mutation database Database of Germline p53 Mutations MUTP53LOAD, Mutant p53 Loss Of Activity Database LRG_321 |